Our SAFC
® portfolio of high-quality products for biopharmaceutical processing withstands strict quality control procedures and is produced according to MQ-500 requirements as defined by the M-Clarity program.
M-Clarity ProgramAs part of our EMPROVE
® Program, our raw materials are offered with EMPROVE
® Dossiers which provide comprehensive, up-to-date documentation to help you navigate regulatory challenges, manage risks, and improve your manufacturing processes.
Our comprehensive portfolio of upstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for production of classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. Trust us to deliver supply chain transparency and reliable sourcing around the globe, streamlining your product qualification with best-in-class regulatory support and service.
5,10,15,20-四苯基-21H,23H-卟吩羰基钌(II)，5,10,15,20-Tetraphenyl-21H,23H-porphine ruthenium(II) carbonyl；Dye content ~80 %
18β-甘草次酸，18β-Glycyrrhetinic acid；97%
介孔碳，Carbon, mesoporous；powder
丁酰氯，Butyryl chloride；98%
氧化镧(III)，Lanthanum(III) oxide；for atomic absorption spectroscopy, ≥99.5%
转化酶来源于面包酵母(酿酒酵母)，Invertase from baker's yeast (S. cerevisiae)；200-300 units/mg solid